Compounds > ursodeoxycholic acid
Page last updated: 2024-08-23

ursodeoxycholic acid and Carcinoma, Anaplastic

ursodeoxycholic acid has been researched along with Carcinoma, Anaplastic in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (25.00)18.2507
2000's2 (50.00)29.6817
2010's1 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hanski, C; Hanski, ML; Krishna-Subramanian, S; Lüscher-Firzlaff, J; Peiró-Jordán, R; Zeitz, M1
Choi, SH; Choi, YH; Im, E; Kim, ND; Suh, H; Yoo, YH1
Cao, M; Hanski, C; Hanski, ML; Jahreis, G; Keller, S; Loddenkemper, C; Stein, H; Zeitz, M1
Beste, JE; Ho, SB; Shekels, LL1

Other Studies

4 other study(ies) available for ursodeoxycholic acid and Carcinoma, Anaplastic

ArticleYear
The chemopreventive agent ursodeoxycholic acid inhibits proliferation of colon carcinoma cells by suppressing c-Myc expression.
    European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP), 2012, Volume: 21, Issue:5

    Topics: Antineoplastic Agents; Carcinoma; Cell Line, Tumor; Cell Proliferation; Colonic Neoplasms; HCT116 Cells; Humans; Proto-Oncogene Proteins c-myc; Ursodeoxycholic Acid

2012
Synthetic bile acid derivatives induce apoptosis through a c-Jun N-terminal kinase and NF-kappaB-dependent process in human cervical carcinoma cells.
    Cancer letters, 2005, Nov-08, Volume: 229, Issue:1

    Topics: Apoptosis; Bile Acids and Salts; Carcinoma; Cell Proliferation; Chenodeoxycholic Acid; DNA Damage; Enzyme Activation; Female; Humans; JNK Mitogen-Activated Protein Kinases; NF-kappa B; Phosphorylation; Tumor Cells, Cultured; Ursodeoxycholic Acid; Uterine Cervical Neoplasms

2005
Prevention of colitis-associated carcinogenesis in a mouse model by diet supplementation with ursodeoxycholic acid.
    International journal of cancer, 2006, Jun-01, Volume: 118, Issue:11

    Topics: Administration, Oral; Animals; Bile Acids and Salts; Carcinoma; Cell Transformation, Neoplastic; Cholagogues and Choleretics; Colitis; Colon; Colorectal Neoplasms; Diet; Disease Models, Animal; Female; Mice; Mice, Inbred C57BL; Ursodeoxycholic Acid

2006
Tauroursodeoxycholic acid protects in vitro models of human colonic cancer cells from cytotoxic effects of hydrophobic bile acids.
    The Journal of laboratory and clinical medicine, 1996, Volume: 127, Issue:1

    Topics: Bile Acids and Salts; Carcinoma; Cell Division; Colonic Neoplasms; Cytotoxins; Humans; Taurodeoxycholic Acid; Tumor Cells, Cultured; Ursodeoxycholic Acid

1996